Antihypertensive 4-aminoquinolines

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424250, 424249, 544182, 544212, 544295, 544357, 544363, A61K 31505, C07D40100

Patent

active

041593316

ABSTRACT:
Antihypertensive compounds for the treatment of hypertensive mammals, including man, of the formula III: ##STR1## wherein X is chloro or trifluoromethyl; wherein R is a radical such as triazinyl, pyrazinyl, pyridinyl, pyrimidinyl, phenyl, or the above radicals substituted by one or two trifluoromethyl, halo, alkyl, alkoxy, dialkylamino or alkylthio groups; or R is the group ##STR2## in which R.sub.1 is phenyl, phenyl substituted with one or two halo atoms, alkoxy or alkyl groups, trifluoromethyl, or R.sub.1 is alkylphenylsulfonyl; or R is the group --SO.sub.2 R.sub.2, in which R.sub.2 is dialkylamino, phenyl, phenyl substituted with halo atoms, alkyl, or alkoxy groups, or trifluoromethyl are prepared from (7-chloro)- or (7-trifluoromethyl)-4-chloroquinoline or 1-[[4-[[(7-chloro)- or (7-trifluoromethyl)quinolinyl]amino]phenyl]sulfonyl]piperazine.

REFERENCES:
patent: 3362956 (1968-01-01), Archer
patent: 3992382 (1976-11-01), Coverdale et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antihypertensive 4-aminoquinolines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antihypertensive 4-aminoquinolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antihypertensive 4-aminoquinolines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1558676

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.